⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study

Official Title: Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study

Study ID: NCT04539327

Interventions

Rucaparib

Study Description

Brief Summary: The study consists of a retrospective observational, multicenter study in which the fundamental exposure factor being investigated is a drug (rucaparib). A clinical database will be built including clinical data in three scenarios of rucaparib treatment: (1) platinum-sensitive BRCA-mutated patients after progression, (2) maintenance therapy in patients after a platinum-sensitive relapse in response, and (3) treatment therapy in BRCA-mutated patients who are currently platinum-resistant. The specific objectives of the study are: * To describe patient characteristics/medical history, safety, efficacy, and dosing of on-label treatment with rucaparib in real-world patients (real-world data). * To describe patient characteristics/medical history, safety, efficacy, and dosing of all patients treated with rucaparib (including patients with on-label treatment and others) in real-world patients (real-world data). * To show that data obtained in clinical trials could be reproduced in non-screened patients.

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

Hospital Torrecárdenas, Almería, Andalucía, Spain

Hospital Universitario Virgen de la Victoria, Málaga, Andalucía, Spain

Hospital Universitario Virgen del Rocío, Sevilla, Andalucía, Spain

Hospital Universitario Nuestra Señora de Valme, Sevilla, Andalucía, Spain

Hospital General San Jorge, Huesca, Aragón, Spain

Hospital Clínico Universitario Lozano Blesa, Zaragoza, Aragón, Spain

Hospital Universitario Miguel Servet, Zaragoza, Aragón, Spain

Hospital del Mar, Barcelona, Catalunya, Spain

Hospital Clínic i Provincial, Barcelona, Catalunya, Spain

Instituto Valenciano De Oncologia, Valencia, Comunitat Valenciana, Spain

Hospital Universitari i Politecnic La Fe, Valencia, Comunitat Valenciana, Spain

Hospital Público Lluis Alcanyis, Xàtiva, Comunitat Valenciana, Spain

Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Galicia, Spain

Hospital Universitario Son Espases, Palma De Mallorca, Islas Baleares, Spain

Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, Spain

Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, Spain

Hospital Universitario de Araba Txagorritxu, Gasteiz / Vitoria, País Basco, Spain

Clínica Universidad de Navarra, Madrid, , Spain

MD Anderson Cancer Center, Madrid, , Spain

Hospital Clínico San Carlos, Madrid, , Spain

Hospital Universitario Fundación Jiménez Díaz, Madrid, , Spain

Hospital Universitario 12 Octubre, Madrid, , Spain

Centro Integral Oncológico Clara Campal, Madrid, , Spain

Contact Details

Name: Alfonso Yubero, Dr.

Affiliation: Hospital Clínico Universitario Lozano Blesa

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: